Hematopoietic Stem Cell Expansion Precedes the Generation of Committed Myeloid Leukemia-Initiating Cells in C/EBPα Mutant AML

Cancer Cell

Volumn 16, Issue 5, 2009, Pages 390-400

  Bereshchenko, Oxana ^a   Mancini, Elena ^a   Moore, Susan ^a   Bilbao, Daniel ^a   Månsson, Robert ^b   Luc, Sidinh ^c   Grover, Amit ^a   Jacobsen, Sten Eirik W ^c   Bryder, David ^b   Nerlov, Claus ^a,d  

^a EUROPEAN MOLECULAR BIOLOGY LABORATORY EMBL   (Italy)

^b LUND UNIVERSITY   (Sweden)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

CELLCYCLE; STEMCELL

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN ALPHA;

ACUTE GRANULOCYTIC LEUKEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; GENE MUTATION; HEMATOPOIETIC STEM CELL; HOMEOSTASIS; HOMOZYGOSITY; MOUSE; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CCAAT-ENHANCER-BINDING PROTEIN-ALPHA; CELL CYCLE; CELL GROWTH PROCESSES; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; GENE EXPRESSION REGULATION, LEUKEMIC; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKEMIA, MYELOID, ACUTE; MICE; MICE, KNOCKOUT;

EID: 70350497395     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccr.2009.09.036     Document Type: Article

References (36)

1. Adolfsson J., Mansson R., Buza-Vidas N., Hultquist A., Liuba K., Jensen C.T., Bryder D., Yang L., Borge O.J., Thoren L.A., et al. Identification of Flt3+ lympho-myeloid stem cells lacking erythro-megakaryocytic potential a revised road map for adult blood lineage commitment. Cell 121 (2005) 295-306
2. Akashi K., Traver D., Miyamoto T., and Weissman I.L. A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature 404 (2000) 193-197
3. Bonnet D., and Dick J.E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat. Med. 3 (1997) 730-737
4. Chen W., Kumar A.R., Hudson W.A., Li Q., Wu B., Staggs R.A., Lund E.A., Sam T.N., and Kersey J.H. Malignant transformation initiated by Mll-AF9: Gene dosage and critical target cells. Cancer Cell 13 (2008) 432-440
5. Cozzio A., Passegue E., Ayton P.M., Karsunky H., Cleary M.L., and Weissman I.L. Similar MLL-associated leukemias arising from self-renewing stem cells and short-lived myeloid progenitors. Genes Dev. 17 (2003) 3029-3035
6. Hasemann M.S., Damgaard I., Schuster M.B., Theilgaard-Monch K., Sorensen A.B., Mrsic A., Krugers T., Ylstra B., Pedersen F.S., Nerlov C., and Porse B.T. Mutation of C/EBPalpha predisposes to the development of myeloid leukemia in a retroviral insertional mutagenesis screen. Blood 111 (2008) 4309-4321
7. Heath V., Suh H.C., Holman M., Renn K., Gooya J.M., Parkin S., Klarmann K.D., Ortiz M., Johnson P., and Keller J. C/EBPalpha deficiency results in hyperproliferation of hematopoietic progenitor cells and disrupts macrophage development in vitro and in vivo. Blood 104 (2004) 1639-1647
8. Higuchi M., O'Brien D., Kumaravelu P., Lenny N., Yeoh E.J., and Downing J.R. Expression of a conditional AML1-ETO oncogene bypasses embryonic lethality and establishes a murine model of human t(8;21) acute myeloid leukemia. Cancer Cell 1 (2002) 63-74
9. Hu M., Krause D., Greaves M., Sharkis S., Dexter M., Heyworth C., and Enver T. Multilineage gene expression precedes commitment in the hemopoietic system. Genes Dev. 11 (1997) 774-785
10. Huntly B.J., Shigematsu H., Deguchi K., Lee B.H., Mizuno S., Duclos N., Rowan R., Amaral S., Curley D., Williams I.R., et al. MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors. Cancer Cell 6 (2004) 587-596
11. Jordan C.T., Astle C.M., Zawadzki J., Mackarehtschian K., Lemischka I.R., and Harrison D.E. Long-term repopulating abilities of enriched fetal liver stem cells measured by competitive repopulation. Exp. Hematol. 23 (1995) 1011-1015
12. Kelly L.M., and Gilliland D.G. Genetics of myeloid leukemias. Annu. Rev. Genomics Hum. Genet. 3 (2002) 179-198
13. Kirstetter P., Schuster M.B., Bereshchenko O., Moore S., Dvinge H., Kurz E., Theilgaard-Monch K., Mansson R., Pedersen T.A., Pabst T., et al. Modeling of C/EBPalpha mutant acute myeloid leukemia reveals a common expression signature of committed myeloid leukemia-initiating cells. Cancer Cell 13 (2008) 299-310
14. Kottaridis P.D., Gale R.E., Langabeer S.E., Frew M.E., Bowen D.T., and Linch D.C. Studies of FLT3 mutations in paired presentation and relapse samples from patients with acute myeloid leukemia: Implications for the role of FLT3 mutations in leukemogenesis, minimal residual disease detection, and possible therapy with FLT3 inhibitors. Blood 100 (2002) 2393-2398
15. Kuo Y.H., Landrette S.F., Heilman S.A., Perrat P.N., Garrett L., Liu P.P., Le Beau M.M., Kogan S.C., and Castilla L.H. Cbf beta-SMMHC induces distinct abnormal myeloid progenitors able to develop acute myeloid leukemia. Cancer Cell 9 (2006) 57-68
16. Lapidot T., Sirard C., Vormoor J., Murdoch B., Hoang T., Caceres-Cortes J., Minden M., Paterson B., Caligiuri M.A., and Dick J.E. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 367 (1994) 645-648
17. Lee B.H., Tothova Z., Levine R.L., Anderson K., Buza-Vidas N., Cullen D.E., McDowell E.P., Adelsperger J., Frohling S., Huntly B.J., et al. FLT3 mutations confer enhanced proliferation and survival properties to multipotent progenitors in a murine model of chronic myelomonocytic leukemia. Cancer Cell 12 (2007) 367-380
18. Leroy H., Roumier C., Huyghe P., Biggio V., Fenaux P., and Preudhomme C. CEBPA point mutations in hematological malignancies. Leukemia 19 (2005) 329-334
19. Mansson R., Hultquist A., Luc S., Yang L., Anderson K., Kharazi S., Al-Hashmi S., Liuba K., Thoren L., Adolfsson J., et al. Molecular evidence for hierarchical transcriptional lineage priming in fetal and adult stem cells and multipotent progenitors. Immunity 26 (2007) 407-419
20. Marcucci G., Maharry K., Radmacher M.D., Mrozek K., Vukosavljevic T., Paschka P., Whitman S.P., Langer C., Baldus C.D., Liu C.G., et al. Prognostic significance of, and gene and microRNA expression signatures associated with, CEBPA mutations in cytogenetically normal acute myeloid leukemia with high-risk molecular features: A Cancer and Leukemia Group B Study. J. Clin. Oncol. 26 (2008) 5078-5087
21. Moore M.A. Converging pathways in leukemogenesis and stem cell self-renewal. Exp. Hematol. 33 (2005) 719-737
22. Nerlov C. C/EBPalpha mutations in acute myeloid leukaemias. Nat. Rev. Cancer 4 (2004) 394-400
23. Nerlov C. The C/EBP family of transcription factors: A paradigm for interaction between gene expression and proliferation control. Trends Cell Biol. 17 (2007) 318-324
24. Nygren J.M., Bryder D., and Jacobsen S.E. Prolonged cell cycle transit is a defining and developmentally conserved hemopoietic stem cell property. J. Immunol. 177 (2006) 201-208
25. Pabst T., and Mueller B.U. Transcriptional dysregulation during myeloid transformation in AML. Oncogene 26 (2007) 6829-6837
26. Porse B.T., Bryder D., Theilgaard-Monch K., Hasemann M.S., Anderson K., Damgaard I., Jacobsen S.E., and Nerlov C. Loss of C/EBP alpha cell cycle control increases myeloid progenitor proliferation and transforms the neutrophil granulocyte lineage. J. Exp. Med. 202 (2005) 85-96
27. Porse B.T., Pedersen T.A., Xu X., Lindberg B., Wewer U.M., Friis-Hansen L., and Nerlov C. E2F repression by C/EBPalpha is required for adipogenesis and granulopoiesis in vivo. Cell 107 (2001) 247-258
28. Pronk C.J., Rossi D.J., Mansson R., Attema J.L., Norddahl G.L., Chan C.K., Sigvardsson M., Weissman I.L., and Bryder D. Elucidation of the phenotypic, functional, and molecular topography of a myeloerythroid progenitor cell hierarchy. Cell Stem Cell 1 (2007) 428-442
29. Shih L.Y., Huang C.F., Wu J.H., Lin T.L., Dunn P., Wang P.N., Kuo M.C., Lai C.L., and Hsu H.C. Internal tandem duplication of FLT3 in relapsed acute myeloid leukemia: A comparative analysis of bone marrow samples from 108 adult patients at diagnosis and relapse. Blood 100 (2002) 2387-2392
30. Shih L.Y., Huang C.F., Wu J.H., Wang P.N., Lin T.L., Dunn P., Chou M.C., Kuo M.C., and Tang C.C. Heterogeneous patterns of FLT3 Asp(835) mutations in relapsed de novo acute myeloid leukemia: A comparative analysis of 120 paired diagnostic and relapse bone marrow samples. Clin. Cancer Res. 10 (2004) 1326-1332
31. Shih L.Y., Liang D.C., Huang C.F., Wu J.H., Lin T.L., Wang P.N., Dunn P., Kuo M.C., and Tang T.C. AML patients with CEBPalpha mutations mostly retain identical mutant patterns but frequently change in allelic distribution at relapse: A comparative analysis on paired diagnosis and relapse samples. Leukemia 20 (2006) 604-609
32. Somervaille T.C., and Cleary M.L. Identification and characterization of leukemia stem cells in murine MLL-AF9 acute myeloid leukemia. Cancer Cell 10 (2006) 257-268
33. Subramanian A., Tamayo P., Mootha V.K., Mukherjee S., Ebert B.L., Gillette M.A., Paulovich A., Pomeroy S.L., Golub T.R., Lander E.S., and Mesirov J.P. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 102 (2005) 15545-15550
34. Taussig D.C., Miraki-Moud F., Anjos-Afonso F., Pearce D.J., Allen K., Ridler C., Lillington D., Oakervee H., Cavenagh J., Agrawal S.G., et al. Anti-CD38 antibody-mediated clearance of human repopulating cells masks the heterogeneity of leukemia-initiating cells. Blood 112 (2008) 568-575
35. Venezia T.A., Merchant A.A., Ramos C.A., Whitehouse N.L., Young A.S., Shaw C.A., and Goodell M.A. Molecular signatures of proliferation and quiescence in hematopoietic stem cells. PLoS Biol. 2 (2004) e301
36. Zhang P., Iwasaki-Arai J., Iwasaki H., Fenyus M.L., Dayaram T., Owens B.M., Shigematsu H., Levantini E., Huettner C.S., Lekstrom-Himes J.A., et al. Enhancement of hematopoietic stem cell repopulating capacity and self-renewal in the absence of the transcription factor C/EBP alpha. Immunity 21 (2004) 853-863